Merakris Therapeutics Announces Open Enrollment for Phase II Clinical Trial of Subcutaneous Injection Drug for the Treatment of Venous Leg Ulcer

Merakris aims to deliver a first-in-class drug and pioneer a new era within the wound care industry by commercializing regenerative medicine for hard-to-heal wounds RESEARCH TRIANGLE PARK, N.C., Dec. 10, 2024 (GLOBE NEWSWIRE) — Merakris Therape